theory < therapeutic < therapeutics

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by therapeutic

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]

Ident.	Authors (with country if any)	Title
000083 (2020)	Karim Fizazi [France]	[Therapeutic options for genitourinary cancers during the epidemic period of COVID-19].
000151 (2020)	Hélène De Brouwer [France] ; Karine Faure [France] ; Tudi Gozé [France]	[Institutional Psychotherapy during confinement situation: Adaptation of the therapeutic setting in a day hospital. Towards a virtual mental institution].
000207 (2020)	Élodie Matusik [France] ; Mériam Ayadi [France] ; Nicolas Picard [France]	[COVID-19, management, therapeutic and vaccine approaches].
000291 (2020)	Walter Gottlieb Land [France, Allemagne]	Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution.
000376 (2020)	Victor Altmayer [France] ; Samir Saheb [France] ; Benjamin Rohaut [France] ; Clémence Marois [France] ; Albert Cao [France] ; Antonio Gallo [France] ; Loïc Le Guennec [France] ; Nicolas Weiss [France] ; Sophie Demeret [France]	Therapeutic plasma exchange in a critically ill Covid-19 patient.
000377 (2020)	Aurélien Mary [France] ; Lucie Hénaut [France] ; Jean-Luc Schmit [France] ; Jean-Philippe Lanoix [France] ; Michel Brazier [France]	Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
000562 (2020)	Manish Sarkar [Inde] ; Soham Saha [France]	Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.
000575 (2020)	Marion Delafosse [France] ; Camille Saint-Jaques [France] ; Camille Petit-Hoang [France] ; Hélène François [France] ; Julie Peltier [France] ; Laurence Nicolet [France] ; Charles Verney [France] ; Martin Viguier [France] ; Emmanuel Letavernier [France] ; Karine Dahan [France]	Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
000884 (2020)	S. Romano-Bertrand [France] ; L-S Aho Glele [France] ; B. Grandbastien [Suisse] ; D. Lepelletier [France]	Preventing SARS-CoV-2 transmission in rehabilitation pools and therapeutic water environments.
000896 (2020)	Emmanuel Novy [France] ; Julien Scala-Bertola [France] ; Claire Roger [France] ; Philippe Guerci [France]	Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.
000950 (2020)	Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink [Pays-Bas] ; Stein Bergan [Norvège] ; Dirk Jan A R. Moes [Pays-Bas] ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France]	Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
000A57 (2020)	Cynthia Tannous [Liban] ; George W. Booz [États-Unis] ; Raffaele Altara [États-Unis, Norvège] ; Dina H. Muhieddine [Liban] ; Mathias Mericskay [France] ; Marwan M. Refaat [Liban] ; Fouad A. Zouein [Liban]	Nicotinamide adenine dinucleotide: Biosynthesis, consumption and therapeutic role in cardiac diseases.
000B26 (2020)	Abdelouaheb Benani [Maroc] ; Sanae Ben Mkaddem [France]	Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
000C59 (2020)	Verena Börger [Allemagne] ; Daniel J. Weiss [États-Unis] ; Johnathon D. Anderson [États-Unis] ; Francesc E. Borràs [Espagne] ; Benedetta Bussolati [Italie] ; David R F. Carter [Royaume-Uni] ; Massimo Dominici [Italie] ; Juan M. Falc N-Pérez [Espagne] ; Mario Gimona [Autriche] ; Andrew F. Hill [Australie] ; Andrew M. Hoffman [États-Unis] ; Dominique De Kleijn [Pays-Bas] ; Bruce L. Levine [États-Unis] ; Rebecca Lim [Australie] ; Jan Lötvall [Suède] ; S Alex Mitsialis [États-Unis] ; Marta Mongui Tortajada [Espagne] ; Maurizio Muraca [Italie] ; Rienk Nieuwland [Pays-Bas] ; Anna Nowocin [Royaume-Uni] ; Lorraine O'Driscoll [Irlande (pays)] ; Luis A. Ortiz [États-Unis] ; Donald G. Phinney [États-Unis] ; Ilona Reischl [Autriche] ; Eva Rohde [Autriche] ; Ralf Sanzenbacher [Allemagne] ; Clotilde Théry [France] ; Wei Seong Toh [Singapour] ; Kenneth W. Witwer [États-Unis] ; Sai Kiang Lim [Singapour] ; Bernd Giebel [Allemagne]	International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19.
000C72 (2020)	Jean-Michel Sallenave [France] ; Loïc Guillot [France]	Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
000C82 (2020)	Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [Luxembourg (pays)] ; Geir Bj Rklund [Norvège]	Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.
001033 (2020)	Eugenio Cavalli [Italie] ; Alessia Bramanti [Italie] ; Rosella Ciurleo [Italie] ; Andrey I. Tchorbanov [Bulgarie] ; Antonio Giordano [États-Unis] ; Paolo Fagone [Italie] ; Cristina Belizna [France] ; Placido Bramanti [Italie] ; Yehuda Shoenfeld [Israël] ; Ferdinando Nicoletti [Italie]	Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review).
001039 (2020)	Antoni Sureda [Espagne] ; Javad Alizadeh [Canada] ; Seyed Fazel Nabavi [Iran] ; Ioana Berindan-Neagoe [Roumanie] ; Cosmin Andrei Cismaru [Roumanie] ; Philippe Jeandet [France] ; Marek J. Łos [Pologne] ; Emilio Clementi [Italie] ; Seyed Mohammad Nabavi [Iran] ; Saeid Ghavami [Pologne]	Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management?
001204 (2020)	Caroline Streicher [France] ; Xavier Engalenc [France] ; Marion Gaudin [France] ; Guillaume Vignaud [France] ; Annick Daulange [France] ; Bruno Abraham [France]	Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report.
001206 (2020)	Chiara Gardin [Italie] ; Letizia Ferroni [Italie] ; Juan Carlos Chachques [France] ; Barbara Zavan [Italie]	Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
001236 (2020)	Fran Robson [Royaume-Uni] ; Khadija Shahed Khan [Hong Kong] ; Thi Khanh Le [France] ; Clément Paris [France] ; Sinem Demirbag [Turquie] ; Peter Barfuss [France] ; Palma Rocchi [France] ; Wai-Lung Ng [Hong Kong]	Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "therapeutic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "therapeutic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    therapeutic
}}

---

This area was generated with Dilib version V0.6.37. Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021